$AHR
American Healthcare REIT, Inc. Stock $ahr

$ahr Overview Financials Valuation SEC Filings Company Website

2024 Q4 Form 10-Q Financial Statement

#000163297024000121 Filed on November 13, 2024

Income Statement

Concept	2024 Q4	2024 Q3
Revenue		$476.8M
YoY Change		14.57%
Cost Of Revenue		$417.1M
YoY Change		11.35%
Gross Profit		$59.71M
YoY Change		43.51%
Gross Profit Margin		12.52%
Selling, General & Admin		$25.07M
YoY Change		-3.26%
% of Gross Profit		41.99%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization		$37.61M
YoY Change		1.84%
% of Gross Profit		62.99%
Operating Expenses		$69.32M
YoY Change		-7.81%
Operating Profit		$93.54M
YoY Change		24.61%
Interest Expense		$30.40M
YoY Change		-27.64%
% of Operating Profit		32.5%
Other Income/Expense, Net		-$36.66M
YoY Change		87.18%
Pretax Income		-$2.830M
YoY Change		-54.07%
Income Tax		$263.0K
% Of Pretax Income
Net Earnings		-$4.126M
YoY Change		-31.11%
Net Earnings / Revenue		-0.87%
Basic Earnings Per Share		-$0.03
Diluted Earnings Per Share		-$0.03
COMMON SHARES
Basic Shares Outstanding	153.1M shares	131.6M shares
Diluted Shares Outstanding		133.7M shares

Balance Sheet

Concept	2024 Q4	2024 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments		$67.85M
YoY Change		92.88%
Cash & Equivalents		$67.85M
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory		$20.23M
Prepaid Expenses
Receivables		$203.7M
Other Receivables		$0.00
Total Short-Term Assets		$271.5M
YoY Change		32.67%
LONG-TERM ASSETS
Property, Plant & Equipment		$3.709B
YoY Change		1.21%
Goodwill		$234.9M
YoY Change		0.0%
Intangibles		$177.8M
YoY Change		-9.69%
Long-Term Investments		$16.26M
YoY Change		-21.86%
Other Assets		$136.6M
YoY Change		4.39%
Total Long-Term Assets		$4.405B
YoY Change		0.48%
TOTAL ASSETS
Total Short-Term Assets		$271.5M
Total Long-Term Assets		$4.405B
Total Assets		$4.677B
YoY Change		1.92%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable		$269.8M
YoY Change		15.33%
Accrued Expenses		$174.2M
YoY Change		-24.63%
Deferred Revenue
YoY Change
Short-Term Debt		$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities		$444.0M
YoY Change		-4.53%
LONG-TERM LIABILITIES
Long-Term Debt		$1.918B
YoY Change		-24.38%
Other Long-Term Liabilities		$57.72M
YoY Change		7.52%
Total Long-Term Liabilities		$1.976B
YoY Change		-23.72%
TOTAL LIABILITIES
Total Short-Term Liabilities		$444.0M
Total Long-Term Liabilities		$1.976B
Total Liabilities		$2.420B
YoY Change		-20.8%
SHAREHOLDERS EQUITY
Retained Earnings		-$1.387B
YoY Change		12.55%
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity		$2.207B
YoY Change
Total Liabilities & Shareholders Equity		$4.677B
YoY Change		1.92%

Cashflow Statement

Concept	2024 Q4	2024 Q3
OPERATING ACTIVITIES
Net Income		-$4.126M
YoY Change		-31.11%
Depreciation, Depletion And Amortization		$37.61M
YoY Change		1.84%
Cash From Operating Activities		$63.13M
YoY Change		116.76%
INVESTING ACTIVITIES
Capital Expenditures		$29.56M
YoY Change		-46.61%
Acquisitions
YoY Change
Other Investing Activities		-$847.0K
YoY Change		-101.28%
Cash From Investing Activities		-$30.41M
YoY Change		-376.08%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities		-13.70M
YoY Change		-73.46%
NET CHANGE
Cash From Operating Activities		63.13M
Cash From Investing Activities		-30.41M
Cash From Financing Activities		-13.70M
Net Change In Cash		19.03M
YoY Change		-265.97%
FREE CASH FLOW
Cash From Operating Activities		$63.13M
Capital Expenditures		$29.56M
Free Cash Flow		$33.57M
YoY Change		-227.95%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	dei	Amendment Flag AmendmentFlag	false
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2024
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2023Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	2548307000	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	1270321000	usd
CY2023Q4	us-gaap	Minority Interest MinorityInterest	155014000	usd
CY2023Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	1425335000	usd
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	4577933000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	1386965000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	1235458000	usd
	us-gaap	Operating Lease Lease Income OperatingLeaseLeaseIncome	140963000	usd
	us-gaap	Operating Lease Lease Income OperatingLeaseLeaseIncome	141134000	usd
CY2023Q3	ahr	Government Grant Income From Cares Act GovernmentGrantIncomeFromCARESAct	1064000	usd
	ahr	Government Grant Income From Cares Act GovernmentGrantIncomeFromCARESAct	0	usd
	ahr	Government Grant Income From Cares Act GovernmentGrantIncomeFromCARESAct	7445000	usd
CY2024Q3	ahr	Revenuesand Government Grant Income From Cares Act RevenuesandGovernmentGrantIncomeFromCARESAct	523814000	usd
CY2023Q3	ahr	Revenuesand Government Grant Income From Cares Act RevenuesandGovernmentGrantIncomeFromCARESAct	464240000	usd
	ahr	Revenuesand Government Grant Income From Cares Act RevenuesandGovernmentGrantIncomeFromCARESAct	1527928000	usd
CY2024Q3	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	417128000	usd
CY2023Q3	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	374603000	usd
CY2024Q3	us-gaap	Operating Lease Expense OperatingLeaseExpense	13150000	usd
	ahr	Noncash Or Part Noncash Acquisition And Disposals Financing Obligations Assumed NoncashOrPartNoncashAcquisitionAndDisposalsFinancingObligationsAssumed	0	usd
CY2023Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
	dei	Entity Registrant Name EntityRegistrantName	AMERICAN HEALTHCARE REIT, INC.
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	MD
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	47-2887436
	dei	Entity Address Address Line1 EntityAddressAddressLine1	18191 Von Karman Avenue
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Entity Address Address Line2 EntityAddressAddressLine2	Suite 300
	dei	Entity Address City Or Town EntityAddressCityOrTown	Irvine
CY2024Q3	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2023Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	1425335000	usd
CY2024Q3	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	3594917000	usd
CY2024Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-1386791000	usd
CY2024Q3	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-2153000	usd
CY2024Q3	us-gaap	Stockholders Equity StockholdersEquity	2207491000	usd
CY2024Q3	us-gaap	Minority Interest MinorityInterest	49473000	usd
CY2024Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	2256964000	usd
CY2024Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	4677012000	usd
CY2024Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	476834000	usd
CY2023Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	416206000	usd
CY2024Q3	ahr	Government Grant Income From Cares Act GovernmentGrantIncomeFromCARESAct	0	usd
	us-gaap	Profit Loss ProfitLoss	-45928000	usd
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity Address State Or Province EntityAddressStateOrProvince	CA
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	92612
	dei	City Area Code CityAreaCode	949
	dei	Local Phone Number LocalPhoneNumber	270-9200
	dei	Security12b Title Security12bTitle	Common Stock, $0.01 par value per share
	dei	Trading Symbol TradingSymbol	AHR
	dei	Security Exchange Name SecurityExchangeName	NYSE
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	false
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
	dei	Entity Shell Company EntityShellCompany	false
CY2023Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2024Q3	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-1276222000	usd
CY2023Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-2425000	usd
CY2023Q3	us-gaap	Operating Lease Lease Income OperatingLeaseLeaseIncome	46970000	usd
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q3
	dei	Entity Central Index Key EntityCentralIndexKey	0001632970
	dei	Document Period End Date DocumentPeriodEndDate	2024-09-30
CY2024Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	153062404	shares
CY2024Q3	us-gaap	Real Estate Investment Property Net RealEstateInvestmentPropertyNet	3535943000	usd
CY2023Q4	us-gaap	Real Estate Investment Property Net RealEstateInvestmentPropertyNet	3425438000	usd
CY2024Q3	us-gaap	Held To Maturity Securities HeldToMaturitySecurities	90144000	usd
CY2023Q4	us-gaap	Held To Maturity Securities HeldToMaturitySecurities	86935000	usd
CY2024Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	67850000	usd
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	43445000	usd
CY2024Q3	us-gaap	Restricted Cash RestrictedCash	48822000	usd
CY2023Q4	us-gaap	Restricted Cash RestrictedCash	47337000	usd
CY2024Q3	us-gaap	Accounts Receivable Net AccountsReceivableNet	203672000	usd
CY2023Q4	us-gaap	Accounts Receivable Net AccountsReceivableNet	185379000	usd
CY2024Q3	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	177804000	usd
CY2023Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	180470000	usd
CY2024Q3	us-gaap	Goodwill Goodwill	234942000	usd
CY2023Q4	us-gaap	Goodwill Goodwill	234942000	usd
CY2024Q3	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	173018000	usd
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	227846000	usd
CY2024Q3	us-gaap	Other Assets OtherAssets	144817000	usd
CY2023Q4	us-gaap	Other Assets OtherAssets	146141000	usd
CY2024Q3	us-gaap	Assets Assets	4677012000	usd
CY2023Q4	us-gaap	Assets Assets	4577933000	usd
CY2024Q3	us-gaap	Secured Debt SecuredDebt	1282853000	usd
CY2023Q4	us-gaap	Secured Debt SecuredDebt	1302396000	usd
CY2024Q3	us-gaap	Line Of Credit LineOfCredit	595970000	usd
CY2023Q4	us-gaap	Line Of Credit LineOfCredit	1223967000	usd
CY2024Q3	us-gaap	Accounts Payable And Accrued Liabilities Current And Noncurrent AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent	269778000	usd
CY2023Q4	us-gaap	Accounts Payable And Accrued Liabilities Current And Noncurrent AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent	242905000	usd
CY2024Q3	us-gaap	Off Market Lease Unfavorable OffMarketLeaseUnfavorable	5271000	usd
CY2023Q4	us-gaap	Off Market Lease Unfavorable OffMarketLeaseUnfavorable	6095000	usd
CY2024Q3	us-gaap	Operating Lease Liability OperatingLeaseLiability	174213000	usd
CY2023Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	225502000	usd
CY2024Q3	us-gaap	Liabilities Liabilities	2419828000	usd
CY2023Q4	us-gaap	Liabilities Liabilities	3118755000	usd
CY2024Q3	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2023Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2024Q3	us-gaap	Redeemable Noncontrolling Interest Equity Fair Value RedeemableNoncontrollingInterestEquityFairValue	220000	usd
CY2023Q4	us-gaap	Redeemable Noncontrolling Interest Equity Fair Value RedeemableNoncontrollingInterestEquityFairValue	33843000	usd
CY2023Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2024Q3	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2023Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	200000000	shares
CY2024Q3	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	200000000	shares
CY2023Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	usd
	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	1223321000	usd
	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	1117298000	usd
CY2023Q3	us-gaap	Operating Lease Expense OperatingLeaseExpense	14574000	usd
	us-gaap	Operating Lease Expense OperatingLeaseExpense	40200000	usd
	us-gaap	Operating Lease Expense OperatingLeaseExpense	44422000	usd
CY2024Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	11921000	usd
CY2023Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	11342000	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	35495000	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	36169000	usd
CY2024Q3	us-gaap	Business Combination Acquisition Related Costs BusinessCombinationAcquisitionRelatedCosts	3537000	usd
CY2023Q3	us-gaap	Business Combination Acquisition Related Costs BusinessCombinationAcquisitionRelatedCosts	1024000	usd
	us-gaap	Business Combination Acquisition Related Costs BusinessCombinationAcquisitionRelatedCosts	6334000	usd
	us-gaap	Business Combination Acquisition Related Costs BusinessCombinationAcquisitionRelatedCosts	2244000	usd
CY2024Q3	us-gaap	Depreciation And Amortization DepreciationAndAmortization	44246000	usd
CY2023Q3	us-gaap	Depreciation And Amortization DepreciationAndAmortization	49273000	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	132277000	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	138644000	usd
CY2024Q3	us-gaap	Costs And Expenses CostsAndExpenses	489982000	usd
CY2023Q3	us-gaap	Costs And Expenses CostsAndExpenses	450816000	usd
	us-gaap	Costs And Expenses CostsAndExpenses	1437627000	usd
	us-gaap	Costs And Expenses CostsAndExpenses	1338777000	usd
CY2024Q3	us-gaap	Interest Expense InterestExpense	30395000	usd
CY2023Q3	us-gaap	Interest Expense InterestExpense	42005000	usd
	us-gaap	Interest Expense InterestExpense	97429000	usd
	us-gaap	Interest Expense InterestExpense	122006000	usd
CY2024Q3	us-gaap	Gain Loss On Interest Rate Derivative Instruments Not Designated As Hedging Instruments GainLossOnInterestRateDerivativeInstrumentsNotDesignatedAsHedgingInstruments	-8967000	usd
CY2023Q3	us-gaap	Gain Loss On Interest Rate Derivative Instruments Not Designated As Hedging Instruments GainLossOnInterestRateDerivativeInstrumentsNotDesignatedAsHedgingInstruments	3402000	usd
	us-gaap	Gain Loss On Interest Rate Derivative Instruments Not Designated As Hedging Instruments GainLossOnInterestRateDerivativeInstrumentsNotDesignatedAsHedgingInstruments	-2162000	usd
	us-gaap	Gain Loss On Interest Rate Derivative Instruments Not Designated As Hedging Instruments GainLossOnInterestRateDerivativeInstrumentsNotDesignatedAsHedgingInstruments	8200000	usd
CY2024Q3	us-gaap	Gains Losses On Sales Of Investment Real Estate GainsLossesOnSalesOfInvestmentRealEstate	-4000	usd
CY2023Q3	us-gaap	Gains Losses On Sales Of Investment Real Estate GainsLossesOnSalesOfInvestmentRealEstate	31981000	usd
	us-gaap	Gains Losses On Sales Of Investment Real Estate GainsLossesOnSalesOfInvestmentRealEstate	2257000	usd
	us-gaap	Gains Losses On Sales Of Investment Real Estate GainsLossesOnSalesOfInvestmentRealEstate	29777000	usd
CY2024Q3	ahr	Financing Obligations FinancingObligations	39299000	usd
CY2023Q4	ahr	Financing Obligations FinancingObligations	41756000	usd
CY2024Q3	ahr	Security Deposits Prepaid Rentand Other Liabilities SecurityDepositsPrepaidRentandOtherLiabilities	52444000	usd
CY2023Q4	ahr	Security Deposits Prepaid Rentand Other Liabilities SecurityDepositsPrepaidRentandOtherLiabilities	76134000	usd
CY2024Q3	us-gaap	Preferred Stock Value PreferredStockValue	0	usd
CY2024Q3	us-gaap	Operating Lease Lease Income OperatingLeaseLeaseIncome	46980000	usd
	ahr	Revenuesand Government Grant Income From Cares Act RevenuesandGovernmentGrantIncomeFromCARESAct	1384037000	usd
CY2024Q3	us-gaap	Impairment Of Real Estate ImpairmentOfRealEstate	0	usd
CY2023Q3	us-gaap	Impairment Of Real Estate ImpairmentOfRealEstate	12510000	usd
	us-gaap	Impairment Of Real Estate ImpairmentOfRealEstate	0	usd
	us-gaap	Impairment Of Real Estate ImpairmentOfRealEstate	12510000	usd
CY2024Q3	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-2123000	usd
CY2023Q3	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-505000	usd
	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-4363000	usd
	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-924000	usd
CY2024Q3	us-gaap	Business Combination Step Acquisition Equity Interest In Acquiree Remeasurement Gain BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain	0	usd
CY2023Q3	us-gaap	Business Combination Step Acquisition Equity Interest In Acquiree Remeasurement Gain BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain	0	usd
	us-gaap	Business Combination Step Acquisition Equity Interest In Acquiree Remeasurement Gain BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain	0	usd
	us-gaap	Business Combination Step Acquisition Equity Interest In Acquiree Remeasurement Gain BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain	726000	usd
CY2024Q3	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	2689000	usd
CY2023Q3	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-1704000	usd
	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	2345000	usd
	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	372000	usd
CY2024Q3	us-gaap	Interest And Other Income InterestAndOtherIncome	2138000	usd
CY2023Q3	us-gaap	Interest And Other Income InterestAndOtherIncome	1755000	usd
	us-gaap	Interest And Other Income InterestAndOtherIncome	7107000	usd
	us-gaap	Interest And Other Income InterestAndOtherIncome	5952000	usd
CY2024Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-36662000	usd
CY2023Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-19586000	usd
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-92245000	usd
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-90413000	usd
CY2024Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-2830000	usd
CY2023Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-6162000	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-1944000	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-45153000	usd
CY2024Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	263000	usd
CY2023Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	284000	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	1227000	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	775000	usd
CY2024Q3	us-gaap	Profit Loss ProfitLoss	-3093000	usd
CY2023Q3	us-gaap	Profit Loss ProfitLoss	-6446000	usd
	us-gaap	Profit Loss ProfitLoss	-3171000	usd
CY2024Q3	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	1033000	usd
CY2023Q3	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-457000	usd
	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	2868000	usd
	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-1884000	usd
CY2024Q3	us-gaap	Net Income Loss NetIncomeLoss	-4126000	usd
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	-5989000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-6039000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-44044000	usd
CY2024Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.03
CY2023Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.09
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.05
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.67
CY2024Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.03
CY2023Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.09
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.05
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.67
CY2024Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	133732745	shares
CY2023Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	66048991	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	122893049	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	66036253	shares
CY2024Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	133732745	shares
CY2023Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	66048991	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	122893049	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	66036253	shares
CY2024Q3	us-gaap	Profit Loss ProfitLoss	-3093000	usd
CY2023Q3	us-gaap	Profit Loss ProfitLoss	-6446000	usd
	us-gaap	Profit Loss ProfitLoss	-3171000	usd
	us-gaap	Profit Loss ProfitLoss	-45928000	usd
CY2024Q3	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	303000	usd
CY2023Q3	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-180000	usd
	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	272000	usd
	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	66000	usd
CY2024Q3	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	303000	usd
CY2023Q3	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-180000	usd
	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	272000	usd
	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	66000	usd
CY2024Q3	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-2790000	usd
CY2023Q3	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-6626000	usd
	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-2899000	usd
	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-45862000	usd
CY2024Q3	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	1033000	usd
CY2023Q3	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	-457000	usd
	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	2868000	usd
	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	-1884000	usd
CY2024Q3	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-3823000	usd
CY2023Q3	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-6169000	usd
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-5767000	usd
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-43978000	usd
CY2024Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	2103893000	usd
CY2024Q3	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	471236000	usd
CY2024Q3	us-gaap	Adjustments To Additional Paid In Capital Stock Issued Issuance Costs AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts	20956000	usd
CY2024Q3	us-gaap	Stock Issued During Period Value Conversion Of Units StockIssuedDuringPeriodValueConversionOfUnits	0	usd
CY2024Q3	us-gaap	Conversion Of Stock Amount Converted1 ConversionOfStockAmountConverted1	0	usd
CY2024Q3	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	2630000	usd
CY2024Q3	us-gaap	Minority Interest Decrease From Redemptions MinorityInterestDecreaseFromRedemptions	-258001000	usd
CY2024Q3	us-gaap	Minority Interest Decrease From Distributions To Noncontrolling Interest Holders MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders	667000	usd
CY2024Q3	ahr	Adjustments To Additional Paid In Capital Adjustment To Redeemable Noncontrolling Interests AdjustmentsToAdditionalPaidInCapitalAdjustmentToRedeemableNoncontrollingInterests	-3000	usd
CY2024Q3	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.25
CY2024Q3	us-gaap	Dividends Common Stock DividendsCommonStock	38380000	usd
CY2024Q3	ahr	Net Income Lossincluding Portion Attributableto Noncontrolling Interest Excluding Preferred Stock Dividend NetIncomeLossincludingPortionAttributabletoNoncontrollingInterestExcludingPreferredStockDividend	-3097000	usd
CY2024Q3	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	303000	usd
CY2024Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	2256964000	usd
CY2023Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	1496402000	usd
CY2023Q3	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	1558000	usd
CY2023Q3	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	21000	usd
CY2023Q3	us-gaap	Minority Interest Decrease From Distributions To Noncontrolling Interest Holders MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders	764000	usd
CY2023Q3	ahr	Reclassification Of Noncontrolling Interest Net ReclassificationOfNoncontrollingInterestNet	-21000	usd
CY2023Q3	ahr	Adjustments To Additional Paid In Capital Adjustment To Redeemable Noncontrolling Interests AdjustmentsToAdditionalPaidInCapitalAdjustmentToRedeemableNoncontrollingInterests	324000	usd
CY2023Q3	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.25
CY2023Q3	us-gaap	Dividends Common Stock DividendsCommonStock	16616000	usd
CY2023Q3	ahr	Net Income Lossincluding Portion Attributableto Noncontrolling Interest Excluding Preferred Stock Dividend NetIncomeLossincludingPortionAttributabletoNoncontrollingInterestExcludingPreferredStockDividend	-6368000	usd
CY2023Q3	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-180000	usd
CY2023Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	1473708000	usd
	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	1244036000	usd
	us-gaap	Adjustments To Additional Paid In Capital Stock Issued Issuance Costs AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts	74498000	usd
CY2024Q3	us-gaap	Stock Issued During Period Value Conversion Of Units StockIssuedDuringPeriodValueConversionOfUnits	0	usd
	us-gaap	Conversion Of Stock Amount Converted1 ConversionOfStockAmountConverted1	0	usd
	us-gaap	Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures	-71000	usd
	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	7309000	usd
	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	21000	usd
	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	14000	usd
	us-gaap	Minority Interest Decrease From Redemptions MinorityInterestDecreaseFromRedemptions	-258442000	usd
	us-gaap	Minority Interest Decrease From Distributions To Noncontrolling Interest Holders MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders	2634000	usd
	ahr	Reclassification Of Noncontrolling Interest Net ReclassificationOfNoncontrollingInterestNet	15282000	usd
	ahr	Adjustments To Additional Paid In Capital Adjustment To Redeemable Noncontrolling Interests AdjustmentsToAdditionalPaidInCapitalAdjustmentToRedeemableNoncontrollingInterests	-8041000	usd
	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.75
	us-gaap	Dividends Common Stock DividendsCommonStock	104530000	usd
	ahr	Net Income Lossincluding Portion Attributableto Noncontrolling Interest Excluding Preferred Stock Dividend NetIncomeLossincludingPortionAttributabletoNoncontrollingInterestExcludingPreferredStockDividend	-3143000	usd
	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	272000	usd
CY2024Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	2256964000	usd
CY2022Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	1567765000	usd
	us-gaap	Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures	-72000	usd
	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	4173000	usd
	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	62000	usd
	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	165000	usd
	us-gaap	Minority Interest Decrease From Distributions To Noncontrolling Interest Holders MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders	6958000	usd
	ahr	Reclassification Of Noncontrolling Interest Net ReclassificationOfNoncontrollingInterestNet	-62000	usd
	ahr	Adjustments To Additional Paid In Capital Adjustment To Redeemable Noncontrolling Interests AdjustmentsToAdditionalPaidInCapitalAdjustmentToRedeemableNoncontrollingInterests	-4098000	usd
	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.75
	us-gaap	Dividends Common Stock DividendsCommonStock	49835000	usd
	ahr	Net Income Lossincluding Portion Attributableto Noncontrolling Interest Excluding Preferred Stock Dividend NetIncomeLossincludingPortionAttributabletoNoncontrollingInterestExcludingPreferredStockDividend	-45364000	usd
	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	66000	usd
CY2023Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	1473708000	usd
CY2024Q3	us-gaap	Net Income Loss Attributable To Redeemable Noncontrolling Interest NetIncomeLossAttributableToRedeemableNoncontrollingInterest	4000	usd
CY2023Q3	us-gaap	Net Income Loss Attributable To Redeemable Noncontrolling Interest NetIncomeLossAttributableToRedeemableNoncontrollingInterest	-78000	usd
	us-gaap	Net Income Loss Attributable To Redeemable Noncontrolling Interest NetIncomeLossAttributableToRedeemableNoncontrollingInterest	-28000	usd
	us-gaap	Net Income Loss Attributable To Redeemable Noncontrolling Interest NetIncomeLossAttributableToRedeemableNoncontrollingInterest	-564000	usd
	us-gaap	Profit Loss ProfitLoss	-3171000	usd
	us-gaap	Profit Loss ProfitLoss	-45928000	usd
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	132277000	usd
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	138644000	usd
	ahr	Other Amortization OtherAmortization	32299000	usd
	ahr	Other Amortization OtherAmortization	46576000	usd
	us-gaap	Straight Line Rent Adjustments StraightLineRentAdjustments	-2563000	usd
	us-gaap	Straight Line Rent Adjustments StraightLineRentAdjustments	-2896000	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	7833000	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	4235000	usd
	us-gaap	Gains Losses On Sales Of Investment Real Estate GainsLossesOnSalesOfInvestmentRealEstate	2257000	usd
	us-gaap	Gains Losses On Sales Of Investment Real Estate GainsLossesOnSalesOfInvestmentRealEstate	29777000	usd
	us-gaap	Impairment Of Real Estate ImpairmentOfRealEstate	0	usd
	us-gaap	Impairment Of Real Estate ImpairmentOfRealEstate	12510000	usd
	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-4363000	usd
	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-924000	usd
	us-gaap	Business Combination Step Acquisition Equity Interest In Acquiree Remeasurement Gain BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain	0	usd
	us-gaap	Business Combination Step Acquisition Equity Interest In Acquiree Remeasurement Gain BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain	726000	usd
	us-gaap	Foreign Currency Transaction Gain Loss Unrealized ForeignCurrencyTransactionGainLossUnrealized	2332000	usd
	us-gaap	Foreign Currency Transaction Gain Loss Unrealized ForeignCurrencyTransactionGainLossUnrealized	351000	usd
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-1406000	usd
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-345000	usd
	us-gaap	Increase Decrease In Other Financial Instruments Used In Operating Activities IncreaseDecreaseInOtherFinancialInstrumentsUsedInOperatingActivities	-2162000	usd
	us-gaap	Increase Decrease In Other Financial Instruments Used In Operating Activities IncreaseDecreaseInOtherFinancialInstrumentsUsedInOperatingActivities	8200000	usd
	us-gaap	Increase Decrease In Accounts And Other Receivables IncreaseDecreaseInAccountsAndOtherReceivables	22020000	usd
	us-gaap	Increase Decrease In Accounts And Other Receivables IncreaseDecreaseInAccountsAndOtherReceivables	19997000	usd
	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	11953000	usd
	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	6817000	usd
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	8075000	usd
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	12375000	usd
	us-gaap	Operating Lease Payments OperatingLeasePayments	25105000	usd
	us-gaap	Operating Lease Payments OperatingLeasePayments	27708000	usd
	ahr	Increase Decrease In Security Deposits Prepaid Rent And Other Liabilities IncreaseDecreaseInSecurityDepositsPrepaidRentAndOtherLiabilities	2436000	usd
	ahr	Increase Decrease In Security Deposits Prepaid Rent And Other Liabilities IncreaseDecreaseInSecurityDepositsPrepaidRentAndOtherLiabilities	443000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	116578000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	72766000	usd
	ahr	Payments To Develop Real Estate Assets And Payments For Capital Expenditures PaymentsToDevelopRealEstateAssetsAndPaymentsForCapitalExpenditures	62256000	usd
	ahr	Payments To Develop Real Estate Assets And Payments For Capital Expenditures PaymentsToDevelopRealEstateAssetsAndPaymentsForCapitalExpenditures	74386000	usd
	us-gaap	Payments To Acquire Real Estate PaymentsToAcquireRealEstate	52107000	usd
	us-gaap	Payments To Acquire Real Estate PaymentsToAcquireRealEstate	45382000	usd
	us-gaap	Proceeds From Sale Of Real Estate Heldforinvestment ProceedsFromSaleOfRealEstateHeldforinvestment	14529000	usd
	us-gaap	Proceeds From Sale Of Real Estate Heldforinvestment ProceedsFromSaleOfRealEstateHeldforinvestment	167861000	usd
	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	0	usd
	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	335000	usd
	us-gaap	Payments To Acquire Equity Method Investments PaymentsToAcquireEquityMethodInvestments	0	usd
	us-gaap	Payments To Acquire Equity Method Investments PaymentsToAcquireEquityMethodInvestments	12000000	usd
	us-gaap	Payments To Acquire Notes Receivable PaymentsToAcquireNotesReceivable	19953000	usd
	us-gaap	Payments To Acquire Notes Receivable PaymentsToAcquireNotesReceivable	13778000	usd
	us-gaap	Proceeds From Collection Of Notes Receivable ProceedsFromCollectionOfNotesReceivable	23683000	usd
	us-gaap	Proceeds From Collection Of Notes Receivable ProceedsFromCollectionOfNotesReceivable	0	usd
	us-gaap	Payments For Proceeds From Deposits On Real Estate Acquisitions PaymentsForProceedsFromDepositsOnRealEstateAcquisitions	-163000	usd
	us-gaap	Payments For Proceeds From Deposits On Real Estate Acquisitions PaymentsForProceedsFromDepositsOnRealEstateAcquisitions	1279000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-95941000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	20701000	usd
	us-gaap	Proceeds From Secured Notes Payable ProceedsFromSecuredNotesPayable	61942000	usd
	us-gaap	Proceeds From Secured Notes Payable ProceedsFromSecuredNotesPayable	85477000	usd
	us-gaap	Repayments Of Secured Debt RepaymentsOfSecuredDebt	211191000	usd
	us-gaap	Repayments Of Secured Debt RepaymentsOfSecuredDebt	96596000	usd
	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit	567800000	usd
	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit	301750000	usd
	us-gaap	Repayments Of Lines Of Credit RepaymentsOfLinesOfCredit	1195991000	usd
	us-gaap	Repayments Of Lines Of Credit RepaymentsOfLinesOfCredit	306484000	usd
	us-gaap	Proceeds From Issuance Of Debt ProceedsFromIssuanceOfDebt	0	usd
	us-gaap	Proceeds From Issuance Of Debt ProceedsFromIssuanceOfDebt	16283000	usd
	ahr	Payments On Financing And Other Obligations PaymentsOnFinancingAndOtherObligations	2967000	usd
	ahr	Payments On Financing And Other Obligations PaymentsOnFinancingAndOtherObligations	34292000	usd
	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	8220000	usd
	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	3418000	usd
	us-gaap	Payments Of Debt Extinguishment Costs PaymentsOfDebtExtinguishmentCosts	0	usd
	us-gaap	Payments Of Debt Extinguishment Costs PaymentsOfDebtExtinguishmentCosts	269000	usd
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	1244036000	usd
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	0	usd
	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	69908000	usd
	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	885000	usd
	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	82591000	usd
	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	59685000	usd
	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	14000	usd
	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	165000	usd
	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	71000	usd
	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	72000	usd
	ahr	Payments To Acquire Noncontrolling Interest PaymentsToAcquireNoncontrollingInterest	258442000	usd
	ahr	Payments To Acquire Noncontrolling Interest PaymentsToAcquireNoncontrollingInterest	0	usd
	us-gaap	Payments Of Dividends Minority Interest PaymentsOfDividendsMinorityInterest	2938000	usd
	us-gaap	Payments Of Dividends Minority Interest PaymentsOfDividendsMinorityInterest	8561000	usd
	us-gaap	Payments For Repurchase Of Redeemable Noncontrolling Interest PaymentsForRepurchaseOfRedeemableNoncontrollingInterest	36083000	usd
	us-gaap	Payments For Repurchase Of Redeemable Noncontrolling Interest PaymentsForRepurchaseOfRedeemableNoncontrollingInterest	15954000	usd
	ahr	Increase Decrease In Security Deposits Financing Activities IncreaseDecreaseInSecurityDepositsFinancingActivities	-123000	usd
	ahr	Increase Decrease In Security Deposits Financing Activities IncreaseDecreaseInSecurityDepositsFinancingActivities	-306000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	5239000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-123177000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	25876000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-29710000	usd
	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	14000	usd
	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-40000	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	90782000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	111906000	usd
CY2024Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	116672000	usd
CY2023Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	82156000	usd
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	43445000	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	65052000	usd
CY2023Q4	us-gaap	Restricted Cash RestrictedCash	47337000	usd
CY2022Q4	us-gaap	Restricted Cash RestrictedCash	46854000	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	90782000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	111906000	usd
CY2024Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	67850000	usd
CY2023Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	35178000	usd
CY2024Q3	us-gaap	Restricted Cash RestrictedCash	48822000	usd
CY2023Q3	us-gaap	Restricted Cash RestrictedCash	46978000	usd
CY2024Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	116672000	usd
CY2023Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	82156000	usd
	us-gaap	Interest Paid Net InterestPaidNet	90807000	usd
	us-gaap	Interest Paid Net InterestPaidNet	114002000	usd
	us-gaap	Income Taxes Paid IncomeTaxesPaid	895000	usd
	us-gaap	Income Taxes Paid IncomeTaxesPaid	1014000	usd
	ahr	Developments And Capital Expenditures Incurred But Not Yet Paid DevelopmentsAndCapitalExpendituresIncurredButNotYetPaid	22848000	usd
	ahr	Developments And Capital Expenditures Incurred But Not Yet Paid DevelopmentsAndCapitalExpendituresIncurredButNotYetPaid	19329000	usd
	ahr	Finance Leases Equipment And Other Obligations Incurred FinanceLeasesEquipmentAndOtherObligationsIncurred	353000	usd
	ahr	Finance Leases Equipment And Other Obligations Incurred FinanceLeasesEquipmentAndOtherObligationsIncurred	1301000	usd
	ahr	Tenant Improvement Overage TenantImprovementOverage	3753000	usd
	ahr	Tenant Improvement Overage TenantImprovementOverage	2359000	usd
	ahr	Noncash Or Part Noncash Acquisition Mortgage Loans Payable Acquired Net Of Loan Discount NoncashOrPartNoncashAcquisitionMortgageLoansPayableAcquiredNetOfLoanDiscount	127254000	usd
	ahr	Noncash Or Part Noncash Acquisition Mortgage Loans Payable Acquired Net Of Loan Discount NoncashOrPartNoncashAcquisitionMortgageLoansPayableAcquiredNetOfLoanDiscount	0	usd
	ahr	Noncashreclassificationofnoncontrollinginterest Noncashreclassificationofnoncontrollinginterest	15282000	usd
	ahr	Noncashreclassificationofnoncontrollinginterest Noncashreclassificationofnoncontrollinginterest	0	usd
	ahr	Issuance Of Common Stock From The Redemption Of Operating Partnership Units IssuanceOfCommonStockFromTheRedemptionOfOperatingPartnershipUnits	25473000	usd
	ahr	Issuance Of Common Stock From The Redemption Of Operating Partnership Units IssuanceOfCommonStockFromTheRedemptionOfOperatingPartnershipUnits	0	usd
CY2024Q3	us-gaap	Dividends Payable Current And Noncurrent DividendsPayableCurrentAndNoncurrent	38218000	usd
CY2023Q3	us-gaap	Dividends Payable Current And Noncurrent DividendsPayableCurrentAndNoncurrent	16559000	usd
CY2024Q3	ahr	Distributions Declared But Not Yet Paid To Limited Partnership Units DistributionsDeclaredButNotYetPaidToLimitedPartnershipUnits	571000	usd
CY2023Q3	ahr	Distributions Declared But Not Yet Paid To Limited Partnership Units DistributionsDeclaredButNotYetPaidToLimitedPartnershipUnits	875000	usd
CY2024Q3	ahr	Distributions Declared But Not Yet Paid To Restricted Stock Units DistributionsDeclaredButNotYetPaidToRestrictedStockUnits	435000	usd
CY2023Q3	ahr	Distributions Declared But Not Yet Paid To Restricted Stock Units DistributionsDeclaredButNotYetPaidToRestrictedStockUnits	140000	usd
CY2024Q3	ahr	Accrued Offering Costs AccruedOfferingCosts	1028000	usd
CY2023Q3	ahr	Accrued Offering Costs AccruedOfferingCosts	1685000	usd
	ahr	Noncash Or Part Noncash Acquisition And Disposals Accounts And Other Receivables Assumed NoncashOrPartNoncashAcquisitionAndDisposalsAccountsAndOtherReceivablesAssumed	343000	usd
	ahr	Noncash Or Part Noncash Acquisition And Disposals Accounts And Other Receivables Assumed NoncashOrPartNoncashAcquisitionAndDisposalsAccountsAndOtherReceivablesAssumed	-1784000	usd
	ahr	Noncash Or Part Noncash Acquisitions And Disposals Increase Decrease In Other Assets Net NoncashOrPartNoncashAcquisitionsAndDisposalsIncreaseDecreaseInOtherAssetsNet	-3868000	usd
	ahr	Noncash Or Part Noncash Acquisitions And Disposals Increase Decrease In Other Assets Net NoncashOrPartNoncashAcquisitionsAndDisposalsIncreaseDecreaseInOtherAssetsNet	-3211000	usd
	ahr	Noncash Or Part Noncash Acquisition And Disposals Payables Assumed NoncashOrPartNoncashAcquisitionAndDisposalsPayablesAssumed	97000	usd
	ahr	Noncash Or Part Noncash Acquisition And Disposals Payables Assumed NoncashOrPartNoncashAcquisitionAndDisposalsPayablesAssumed	-1460000	usd
	ahr	Noncash Or Part Noncash Acquisition And Disposals Financing Obligations Assumed NoncashOrPartNoncashAcquisitionAndDisposalsFinancingObligationsAssumed	12000	usd
	ahr	Noncash Or Part Noncash Acquisition And Disposals Security Deposits Prepaid Rent And Other Liabilities Assumed NoncashOrPartNoncashAcquisitionAndDisposalsSecurityDepositsPrepaidRentAndOtherLiabilitiesAssumed	-236000	usd
	ahr	Noncash Or Part Noncash Acquisition And Disposals Security Deposits Prepaid Rent And Other Liabilities Assumed NoncashOrPartNoncashAcquisitionAndDisposalsSecurityDepositsPrepaidRentAndOtherLiabilitiesAssumed	-458000	usd
	us-gaap	Nature Of Operations NatureOfOperations	<div style="margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">1. Organization and Description of Business</span></div><div style="margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Overview and Background</span></div><div style="margin-top:8pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">American Healthcare REIT, Inc., a Maryland corporation, is a self-managed real estate investment trust, or REIT, that acquires, owns and operates a diversified portfolio of clinical healthcare real estate properties, focusing primarily on outpatient medical buildings, senior housing, skilled nursing facilities, or SNFs, and other healthcare-related facilities. We have built a fully-integrated management platform that operates clinical healthcare properties throughout the United States, the United Kingdom and the Isle of Man. We operate our integrated senior health campuses and senior housing operating properties, or SHOP, utilizing the structure permitted by the REIT Investment Diversification and Empowerment Act of 2007, which is commonly referred to as a “RIDEA” structure. We have also originated and acquired secured loans and may originate or acquire other real estate-related investments in the future on an infrequent and opportunistic basis. We generally seek investments that produce current income; however, we have selectively developed, and may continue to selectively develop, healthcare real estate properties. We have elected to be taxed as a REIT for U.S. federal income tax purposes. We believe that we have been organized and operated, and we intend to continue to operate, in conformity with the requirements for qualification and taxation as a REIT under the Code. </span></div><div style="margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Operating Partnership</span></div><div style="margin-top:8pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We conduct substantially all of our operations through American Healthcare REIT Holdings, LP, or our operating partnership, and we are the sole general partner of our operating partnership. As of December 31, 2023</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">we owned 95.0% of the operating partnership units, or OP units, in our operating partnership, and the remaining 5.0% OP units were owned by the following limited partners: AHI Group Holdings, LLC, which is owned and controlled by Jeffrey T. Hanson, the non-executive Chairman of our board of directors, or our board, Danny Prosky, our Chief Executive Officer, President and director, and Mathieu B. Streiff, one of our directors; Platform Healthcare Investor T-II, LLC; Flaherty Trust; and a wholly owned subsidiary of Griffin Capital Company, LLC. On August 19, 2024, Platform Healthcare Investor T-II, LLC redeemed all of its OP units in exchange for 1,216,571 shares of our Common Stock on a one-for-one basis, and as a result, is no longer a limited partner of our operating partnership. As of September 30, 2024, we owned 98.5% of the OP units in our operating partnership, and the remaining 1.5% of the OP units were owned by the remaining limited partners. See Note 12, Redeemable Noncontrolling Interests, and Note 13, Equity — Noncontrolling Interests in Total Equity, for a further discussion of the ownership in our operating partnership.</span></div><div style="margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Public Offerings and Listing</span></div><div style="margin-top:8pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We issued an aggregate 65,445,557 shares of Class T common stock and Class I common stock, for a total of $2,737,716,000 in gross offering proceeds, since February 26, 2014 in our initial public offerings and our distribution reinvestment plan, or DRIP, offerings. Our initial public offerings were terminated as of April 2019.</span></div><div style="margin-top:8pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On February 9, 2024, pursuant to a Registration Statement filed with the United States Securities and Exchange Commission, or SEC, on Form S-11 (File No. 333-267464), as amended, we closed our underwritten public offering, or the February 2024 Offering, through which we issued 64,400,000 shares of Common Stock, for a total of $772,800,000 in gross offering proceeds. Such amounts include the exercise in full of the underwriters’ overallotment option to purchase up to an additional 8,400,000 shares of Common Stock. These shares are listed on the New York Stock Exchange, or NYSE, under the trading symbol “AHR” and began trading on February 7, 2024. </span></div><div style="margin-top:8pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Following the closing of the February 2024 Offering and until August 5, 2024, we presented Common Stock, Class T common stock and Class I common stock, or collectively, common stock, as separate classes within our condensed consolidated balance sheets and condensed consolidated statements of equity. Any references to “Common Stock” in this Quarterly Report on Form 10-Q refer to our NYSE-listed shares sold through the February 2024 Offering or the September 2024 Offering, as defined below, whereas Class T common stock and Class I common stock refer to our classes of common stock that were not NYSE-listed. This applies to all historical periods presented herein. On August 5, 2024, 180 days after the listing of our Common Stock on the NYSE, each share of our Class T common stock and Class I common stock automatically converted into one share of our listed Common Stock.</span></div><div style="margin-top:8pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On September 20, 2024, we closed our additional underwritten public offering, or the September 2024 Offering, under a prospectus supplement and related prospectus filed with the SEC pursuant to our effective shelf Registration Statement on Form S-3 (File No. 333-281488). Through the September 2024 Offering, we issued 20,010,000 shares of Common Stock, for a total of $471,236,000 in gross offering proceeds. Such amounts include the exercise in full of the underwriters’ overallotment option to purchase up to an additional 2,610,000 shares of Common Stock. These shares are listed on NYSE under the trading symbol “AHR” and began trading on September 19, 2024.</span></div><div style="margin-top:8pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See Note 13, Equity — Common Stock, and Note 13, Equity — Distribution Reinvestment Plan, for a further discussion of our public offerings. </span></div><div style="margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our Real Estate Investments Portfolio</span></div><div style="margin-top:8pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We currently operate through four reportable business segments: integrated senior health campuses, outpatient medical, or OM, SHOP and triple-net leased properties. As of September 30, 2024, we owned and/or operated 324 buildings and integrated senior health campuses, representing approximately 19,676,000 square feet of gross leasable area, for an aggregate contract purchase price of $4,666,399,000. In addition, as of September 30, 2024, we also owned a real estate-related debt investment purchased for $60,429,000.</span></div>
CY2024Q3	us-gaap	Stock Issued During Period Shares Conversion Of Units StockIssuedDuringPeriodSharesConversionOfUnits	1216571	shares
	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	4	segment
CY2024Q3	ahr	Number Of Buildings And Integrated Senior Health Campuses Owned And Or Operated NumberOfBuildingsAndIntegratedSeniorHealthCampusesOwnedAndOrOperated	324	campus
CY2024Q3	us-gaap	Area Of Real Estate Property AreaOfRealEstateProperty	19676000	sqft
	ahr	Acquisition Aggregated Cost Of Acquired Properties Purchase Price Netof Disposals AcquisitionAggregatedCostOfAcquiredPropertiesPurchasePriceNetofDisposals	4666399000	usd
	ahr	Acquisition Aggregated Cost Of Acquired Real Estate Related Investment Purchase Price AcquisitionAggregatedCostOfAcquiredRealEstateRelatedInvestmentPurchasePrice	60429000	usd
	us-gaap	Use Of Estimates UseOfEstimates	<div style="margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="margin-top:8pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of our accompanying condensed consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, as well as the disclosure of contingent assets and liabilities, at the date of our condensed consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Significant items subject to such estimates and assumptions include, but are not limited to, the initial and recurring valuation of certain assets acquired and liabilities assumed through property acquisitions including through business combinations, goodwill and its impairment, revenues and grant income, allowance for credit losses, impairment of long-lived and intangible assets and contingencies. These estimates are made and evaluated on an ongoing basis using information that is currently available, as well as various other assumptions believed to be reasonable under the circumstances. Actual results could differ from those estimates, perhaps in material adverse ways, and those estimates could be different under different assumptions or conditions.</span></div>
	us-gaap	Financing Receivable Allowance For Credit Losses Policy For Uncollectible Amounts FinancingReceivableAllowanceForCreditLossesPolicyForUncollectibleAmounts	<div style="margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Resident and Tenant Receivables and Allowances </span></div><div style="margin-top:8pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Resident receivables, which are related to resident fees and services revenue, are carried net of an allowance for credit losses. An allowance is maintained for estimated losses resulting from the inability of residents and payors to meet the contractual obligations under their lease or service agreements. Substantially all of such allowances are recorded as direct reductions of resident fees and services revenue as contractual adjustments provided to third-party payors or implicit price concessions in our accompanying condensed consolidated statements of operations and comprehensive loss. Our determination of the adequacy of these allowances is based primarily upon evaluations of historical loss experience, the residents’ financial condition, security deposits, cash collection patterns by payor and by state, current economic conditions, future expectations in estimating credit losses and other relevant factors. Tenant receivables, which are related to real estate revenue, and unbilled deferred rent receivables are reduced for amounts where collectability is not probable, which are recognized as direct reductions of real estate revenue in our accompanying condensed consolidated statements of operations and comprehensive loss.</span></div>
CY2023Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	17037000	usd
CY2022Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	14071000	usd
	us-gaap	Allowance For Doubtful Accounts Receivable Period Increase Decrease AllowanceForDoubtfulAccountsReceivablePeriodIncreaseDecrease	20750000	usd
	us-gaap	Allowance For Doubtful Accounts Receivable Period Increase Decrease AllowanceForDoubtfulAccountsReceivablePeriodIncreaseDecrease	14035000	usd
	us-gaap	Allowance For Doubtful Accounts Receivable Write Offs AllowanceForDoubtfulAccountsReceivableWriteOffs	13971000	usd
	us-gaap	Allowance For Doubtful Accounts Receivable Write Offs AllowanceForDoubtfulAccountsReceivableWriteOffs	7011000	usd
	ahr	Accounts Receivable Allowancefor Credit Loss Period Increase Decreasefrom Collectionsor Adjustments AccountsReceivableAllowanceforCreditLossPeriodIncreaseDecreasefromCollectionsorAdjustments	2262000	usd
	ahr	Accounts Receivable Allowancefor Credit Loss Period Increase Decreasefrom Collectionsor Adjustments AccountsReceivableAllowanceforCreditLossPeriodIncreaseDecreasefromCollectionsorAdjustments	6446000	usd
CY2024Q3	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	21554000	usd
CY2023Q3	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	14649000	usd
CY2024Q3	us-gaap	Real Estate Heldforsale RealEstateHeldforsale	0	usd
CY2023Q4	us-gaap	Real Estate Heldforsale RealEstateHeldforsale	3477000	usd
	ahr	Number Of Real Estate Investment To Be Disposed Of NumberOfRealEstateInvestmentToBeDisposedOf	0	property
CY2024Q3	ahr	Reimbursement Of Payroll Related Costs To Managers ReimbursementOfPayrollRelatedCostsToManagers	50966000	usd
CY2023Q4	ahr	Reimbursement Of Payroll Related Costs To Managers ReimbursementOfPayrollRelatedCostsToManagers	42698000	usd
CY2024Q3	us-gaap	Accrued Insurance Current And Noncurrent AccruedInsuranceCurrentAndNoncurrent	46312000	usd
CY2023Q4	us-gaap	Accrued Insurance Current And Noncurrent AccruedInsuranceCurrentAndNoncurrent	44548000	usd
CY2024Q3	us-gaap	Dividends Payable Current And Noncurrent DividendsPayableCurrentAndNoncurrent	38218000	usd
CY2023Q4	us-gaap	Dividends Payable Current And Noncurrent DividendsPayableCurrentAndNoncurrent	16557000	usd
CY2024Q3	us-gaap	Taxes Payable Current And Noncurrent TaxesPayableCurrentAndNoncurrent	28486000	usd
CY2023Q4	us-gaap	Taxes Payable Current And Noncurrent TaxesPayableCurrentAndNoncurrent	23549000	usd
CY2024Q3	ahr	Accrued Development And Capital Expenditures AccruedDevelopmentAndCapitalExpenditures	22848000	usd
CY2023Q4	ahr	Accrued Development And Capital Expenditures AccruedDevelopmentAndCapitalExpenditures	24881000	usd
CY2024Q3	us-gaap	Real Estate Investment Property At Cost RealEstateInvestmentPropertyAtCost	4388808000	usd
CY2023Q4	us-gaap	Real Estate Investment Property At Cost RealEstateInvestmentPropertyAtCost	4177595000	usd
CY2024Q3	us-gaap	Real Estate Investment Property Accumulated Depreciation RealEstateInvestmentPropertyAccumulatedDepreciation	852865000	usd
CY2023Q4	us-gaap	Real Estate Investment Property Accumulated Depreciation RealEstateInvestmentPropertyAccumulatedDepreciation	752157000	usd
CY2024Q3	us-gaap	Real Estate Investment Property Net RealEstateInvestmentPropertyNet	3535943000	usd
CY2023Q4	us-gaap	Real Estate Investment Property Net RealEstateInvestmentPropertyNet	3425438000	usd
CY2024Q3	us-gaap	Depreciation Depreciation	37610000	usd
CY2023Q3	us-gaap	Depreciation Depreciation	36929000	usd
	us-gaap	Depreciation Depreciation	111611000	usd
	us-gaap	Depreciation Depreciation	109967000	usd
CY2024Q3	ahr	Capital Expenditures Incurred CapitalExpendituresIncurred	29267000	usd
	ahr	Capital Expenditures Incurred CapitalExpendituresIncurred	57551000	usd
CY2024Q3	ahr	Number Of Integrated Senior Health Campuses Expanded NumberOfIntegratedSeniorHealthCampusesExpanded	3	campus
	ahr	Number Of Integrated Senior Health Campuses Expanded NumberOfIntegratedSeniorHealthCampusesExpanded	3	campus
	us-gaap	Asset Acquisition Consideration Transferred AssetAcquisitionConsiderationTransferred	45841000	usd
	ahr	Lines Of Credit Related To Acquisition Of Properties LinesOfCreditRelatedToAcquisitionOfProperties	45000000	usd
	ahr	Number Of Real Estate Investment To Be Disposed Of NumberOfRealEstateInvestmentToBeDisposedOf	2	building
	ahr	Contract Sale Price Of Disposition ContractSalePriceOfDisposition	11136000	usd
	us-gaap	Impairment Of Real Estate ImpairmentOfRealEstate	0	usd
CY2024Q3	us-gaap	Impairment Of Real Estate ImpairmentOfRealEstate	0	usd
CY2023Q3	us-gaap	Impairment Of Real Estate ImpairmentOfRealEstate	12510000	usd
	us-gaap	Impairment Of Real Estate ImpairmentOfRealEstate	12510000	usd
CY2023Q3	ahr	Number Of Shop Impaired NumberOfShopImpaired	2	facility
	ahr	Number Of Shop Impaired NumberOfShopImpaired	2	facility
CY2023Q3	ahr	Number Of Shop Reclassified To Properties Held For Sale NumberOfSHOPReclassifiedToPropertiesHeldForSale	1	facility
CY2024Q3	us-gaap	Held To Maturity Securities HeldToMaturitySecurities	90144000	usd
CY2023Q4	us-gaap	Held To Maturity Securities HeldToMaturitySecurities	86935000	usd
CY2024Q3	ahr	Heldto Maturity Debt Securities Unamortizedclosingcosts HeldtoMaturityDebtSecuritiesUnamortizedclosingcosts	251000	usd
CY2023Q4	ahr	Heldto Maturity Debt Securities Unamortizedclosingcosts HeldtoMaturityDebtSecuritiesUnamortizedclosingcosts	489000	usd
CY2024Q3	us-gaap	Accretion Amortization Of Discounts And Premiums Investments AccretionAmortizationOfDiscountsAndPremiumsInvestments	1168000	usd
CY2023Q3	us-gaap	Accretion Amortization Of Discounts And Premiums Investments AccretionAmortizationOfDiscountsAndPremiumsInvestments	1060000	usd
	us-gaap	Accretion Amortization Of Discounts And Premiums Investments AccretionAmortizationOfDiscountsAndPremiumsInvestments	3447000	usd
	us-gaap	Accretion Amortization Of Discounts And Premiums Investments AccretionAmortizationOfDiscountsAndPremiumsInvestments	3126000	usd
CY2024Q3	us-gaap	Amortization Of Deferred Loan Origination Fees Net AmortizationOfDeferredLoanOriginationFeesNet	82000	usd
CY2023Q3	us-gaap	Amortization Of Deferred Loan Origination Fees Net AmortizationOfDeferredLoanOriginationFeesNet	71000	usd
	us-gaap	Amortization Of Deferred Loan Origination Fees Net AmortizationOfDeferredLoanOriginationFeesNet	238000	usd
	us-gaap	Amortization Of Deferred Loan Origination Fees Net AmortizationOfDeferredLoanOriginationFeesNet	204000	usd
CY2024Q3	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	177804000	usd
CY2023Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	180470000	usd
CY2024Q3	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	6652000	usd
CY2023Q3	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	15351000	usd
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	20793000	usd
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	40133000	usd
CY2024Q3	us-gaap	Finite Lived Intangible Asset Useful Life FiniteLivedIntangibleAssetUsefulLife	P6Y6M
CY2023Q4	us-gaap	Finite Lived Intangible Asset Useful Life FiniteLivedIntangibleAssetUsefulLife	P7Y9M18D
CY2024Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear	6360000	usd
CY2024Q3	ahr	Finite Lived Intangible Liabilities Amortization Expenses Remainder Of Fiscal Year FiniteLivedIntangibleLiabilitiesAmortizationExpensesRemainderOfFiscalYear	248000	usd
CY2024Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	12595000	usd
CY2024Q3	ahr	Finite Lived Intangible Liabilities Amortization Expenses Year Two FiniteLivedIntangibleLiabilitiesAmortizationExpensesYearTwo	956000	usd
CY2024Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	7599000	usd
CY2024Q3	ahr	Finite Lived Intangible Liabilities Amortization Expenses Year Three FiniteLivedIntangibleLiabilitiesAmortizationExpensesYearThree	840000	usd
CY2024Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	7075000	usd
CY2024Q3	ahr	Finite Lived Intangible Liabilities Amortization Expenses Year Four FiniteLivedIntangibleLiabilitiesAmortizationExpensesYearFour	825000	usd
CY2024Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	6023000	usd
CY2024Q3	ahr	Finite Lived Intangible Liabilities Amortization Expenses Year Five FiniteLivedIntangibleLiabilitiesAmortizationExpensesYearFive	709000	usd
CY2024Q3	ahr	Finite Lived Intangible Asset Expected Amortization After Year Four FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour	17861000	usd
CY2024Q3	ahr	Finite Lived Intangible Liabilities Amortization Expenses After Year Five FiniteLivedIntangibleLiabilitiesAmortizationExpensesAfterYearFive	1693000	usd
CY2024Q3	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	57513000	usd
CY2024Q3	ahr	Finite Lived Intangible Liabilities Net FiniteLivedIntangibleLiabilitiesNet	5271000	usd
CY2024Q3	us-gaap	Deferred Rent Receivables Net DeferredRentReceivablesNet	50223000	usd
CY2023Q4	us-gaap	Deferred Rent Receivables Net DeferredRentReceivablesNet	47540000	usd
CY2024Q3	ahr	Prepaid Expense Deposits Other Assets And Deferred Tax Assets PrepaidExpenseDepositsOtherAssetsAndDeferredTaxAssets	33037000	usd
CY2023Q4	ahr	Prepaid Expense Deposits Other Assets And Deferred Tax Assets PrepaidExpenseDepositsOtherAssetsAndDeferredTaxAssets	33204000	usd
CY2024Q3	us-gaap	Inventory Net InventoryNet	20234000	usd
CY2023Q4	us-gaap	Inventory Net InventoryNet	19472000	usd
CY2024Q3	us-gaap	Deferred Costs Leasing Accumulated Amortization DeferredCostsLeasingAccumulatedAmortization	7935000	usd
CY2023Q4	us-gaap	Deferred Costs Leasing Accumulated Amortization DeferredCostsLeasingAccumulatedAmortization	7231000	usd
CY2024Q3	us-gaap	Deferred Costs Leasing Net DeferredCostsLeasingNet	18391000	usd
CY2023Q4	us-gaap	Deferred Costs Leasing Net DeferredCostsLeasingNet	17565000	usd
CY2024Q3	us-gaap	Equity Method Investments EquityMethodInvestments	16259000	usd
CY2023Q4	us-gaap	Equity Method Investments EquityMethodInvestments	20611000	usd
CY2024Q3	us-gaap	Accumulated Amortization Deferred Finance Costs AccumulatedAmortizationDeferredFinanceCosts	8504000	usd
CY2023Q4	us-gaap	Accumulated Amortization Deferred Finance Costs AccumulatedAmortizationDeferredFinanceCosts	8494000	usd
CY2024Q3	us-gaap	Deferred Finance Costs Net DeferredFinanceCostsNet	4480000	usd
CY2023Q4	us-gaap	Deferred Finance Costs Net DeferredFinanceCostsNet	3830000	usd
CY2024Q3	ahr	Accumulated Amortization Lease Inducements AccumulatedAmortizationLeaseInducements	2807000	usd
CY2023Q4	ahr	Accumulated Amortization Lease Inducements AccumulatedAmortizationLeaseInducements	2544000	usd
	ahr	Lease Inducements Weighted Average Remaining Life LeaseInducementsWeightedAverageRemainingLife	P6Y2M12D
CY2023Q4	ahr	Lease Inducements Weighted Average Remaining Life LeaseInducementsWeightedAverageRemainingLife	P6Y10M24D
CY2024Q3	us-gaap	Incentive To Lessee IncentiveToLessee	2193000	usd
CY2023Q4	us-gaap	Incentive To Lessee IncentiveToLessee	2456000	usd
CY2024Q3	us-gaap	Derivative Assets DerivativeAssets	0	usd
CY2023Q4	us-gaap	Derivative Assets DerivativeAssets	1463000	usd
CY2024Q3	us-gaap	Other Assets OtherAssets	144817000	usd
CY2023Q4	us-gaap	Other Assets OtherAssets	146141000	usd
CY2024Q3	ahr	Amortizationof Deferred Lease Inducements AmortizationofDeferredLeaseInducements	87000	usd
CY2023Q3	ahr	Amortizationof Deferred Lease Inducements AmortizationofDeferredLeaseInducements	87000	usd
	ahr	Amortizationof Deferred Lease Inducements AmortizationofDeferredLeaseInducements	263000	usd
	ahr	Amortizationof Deferred Lease Inducements AmortizationofDeferredLeaseInducements	263000	usd
CY2024Q3	ahr	Number Of Fixed Rate Mortgage Loans Payable NumberOfFixedRateMortgageLoansPayable	97	mortgageloan
CY2023Q4	ahr	Number Of Fixed Rate Mortgage Loans Payable NumberOfFixedRateMortgageLoansPayable	76	mortgageloan
CY2024Q3	ahr	Number Of Variable Rate Mortgage Loans Payable NumberOfVariableRateMortgageLoansPayable	3	mortgageloan
CY2023Q4	ahr	Number Of Variable Rate Mortgage Loans Payable NumberOfVariableRateMortgageLoansPayable	13	mortgageloan
CY2024Q3	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	1307702000	usd
CY2023Q4	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	1326313000	usd
CY2024Q3	us-gaap	Debt Instrument Unamortized Premium DebtInstrumentUnamortizedPremium	119000	usd
CY2023Q4	us-gaap	Debt Instrument Unamortized Premium DebtInstrumentUnamortizedPremium	167000	usd
CY2024Q3	us-gaap	Debt Instrument Unamortized Discount DebtInstrumentUnamortizedDiscount	14011000	usd
CY2023Q4	us-gaap	Debt Instrument Unamortized Discount DebtInstrumentUnamortizedDiscount	14371000	usd
CY2024Q3	us-gaap	Secured Debt SecuredDebt	1282853000	usd
CY2023Q4	us-gaap	Secured Debt SecuredDebt	1302396000	usd
CY2023Q4	us-gaap	Secured Debt SecuredDebt	1302396000	usd
CY2022Q4	us-gaap	Secured Debt SecuredDebt	1229847000	usd
	ahr	Proceeds From Mortgage Loans ProceedsFromMortgageLoans	61942000	usd
	ahr	Proceeds From Mortgage Loans ProceedsFromMortgageLoans	85477000	usd
	ahr	Assumption Of Debt In Business Combination AssumptionOfDebtInBusinessCombination	127254000	usd
	ahr	Assumption Of Debt In Business Combination AssumptionOfDebtInBusinessCombination	0	usd
	ahr	Amortizationofdeferredfinancingcostsrelatedtomortgage Amortizationofdeferredfinancingcostsrelatedtomortgage	1955000	usd
	ahr	Amortizationofdeferredfinancingcostsrelatedtomortgage Amortizationofdeferredfinancingcostsrelatedtomortgage	1690000	usd
	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	3699000	usd
	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	2662000	usd
	us-gaap	Debt Instrument Periodic Payment Principal DebtInstrumentPeriodicPaymentPrincipal	15219000	usd
	us-gaap	Debt Instrument Periodic Payment Principal DebtInstrumentPeriodicPaymentPrincipal	59931000	usd
	ahr	Early Payoff Of Mortgage Payable EarlyPayoffOfMortgagePayable	195972000	usd
	ahr	Early Payoff Of Mortgage Payable EarlyPayoffOfMortgagePayable	9809000	usd
	ahr	Payoff Of Mortgage Loan Payable Due To Disposition Of Real Estate Investment PayoffOfMortgageLoanPayableDueToDispositionOfRealEstateInvestment	0	usd
	ahr	Payoff Of Mortgage Loan Payable Due To Disposition Of Real Estate Investment PayoffOfMortgageLoanPayableDueToDispositionOfRealEstateInvestment	26856000	usd
	ahr	Capitalizeddeferredfinancingcostsformortgages Capitalizeddeferredfinancingcostsformortgages	3202000	usd
	ahr	Capitalizeddeferredfinancingcostsformortgages Capitalizeddeferredfinancingcostsformortgages	1842000	usd
CY2024Q3	us-gaap	Secured Debt SecuredDebt	1282853000	usd
CY2023Q3	us-gaap	Secured Debt SecuredDebt	1221238000	usd
CY2024Q1	ahr	Early Payoff Of Mortgage Payable EarlyPayoffOfMortgagePayable	176145000	usd
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-345000	usd
CY2024Q3	us-gaap	Long Term Debt Maturities Repayments Of Principal Remainder Of Fiscal Year LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear	33036000	usd
CY2024Q3	us-gaap	Long Term Debt Maturities Repayments Of Principal In Next Twelve Months LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths	303345000	usd
CY2024Q3	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Two LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo	159437000	usd
CY2024Q3	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Three LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree	56716000	usd
CY2024Q3	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Four LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour	139961000	usd
CY2024Q3	ahr	Long Term Debt Maturity After Year Four LongTermDebtMaturityAfterYearFour	615207000	usd
CY2024Q3	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	1307702000	usd
CY2024Q3	ahr	Derivative Number Of Instruments Terminated DerivativeNumberOfInstrumentsTerminated	1	instrument
CY2024Q3	ahr	Derivative Notional Amount Terminated DerivativeNotionalAmountTerminated	200000000	usd
CY2024Q3	ahr	Gain Loss On Extinguishment Of Derivative Instruments GainLossOnExtinguishmentOfDerivativeInstruments	-415000	usd
CY2024Q3	us-gaap	Gain Loss On Interest Rate Derivative Instruments Not Designated As Hedging Instruments GainLossOnInterestRateDerivativeInstrumentsNotDesignatedAsHedgingInstruments	-8967000	usd
CY2023Q3	us-gaap	Gain Loss On Interest Rate Derivative Instruments Not Designated As Hedging Instruments GainLossOnInterestRateDerivativeInstrumentsNotDesignatedAsHedgingInstruments	3402000	usd
	us-gaap	Gain Loss On Interest Rate Derivative Instruments Not Designated As Hedging Instruments GainLossOnInterestRateDerivativeInstrumentsNotDesignatedAsHedgingInstruments	-2162000	usd
	us-gaap	Gain Loss On Interest Rate Derivative Instruments Not Designated As Hedging Instruments GainLossOnInterestRateDerivativeInstrumentsNotDesignatedAsHedgingInstruments	8200000	usd
CY2024Q3	ahr	Limited Liability Company Llc Or Limited Partnership Lp Managing Member Or General Partner Ownership Interest With Redemption Features Outstanding LimitedLiabilityCompanyLLCOrLimitedPartnershipLPManagingMemberOrGeneralPartnerOwnershipInterestWithRedemptionFeaturesOutstanding	0.010
CY2023Q4	ahr	Limited Liability Company Llc Or Limited Partnership Lp Managing Member Or General Partner Ownership Interest With Redemption Features Outstanding LimitedLiabilityCompanyLLCOrLimitedPartnershipLPManagingMemberOrGeneralPartnerOwnershipInterestWithRedemptionFeaturesOutstanding	0.010
CY2023Q4	us-gaap	Redeemable Noncontrolling Interest Equity Fair Value RedeemableNoncontrollingInterestEquityFairValue	33843000	usd
CY2022Q4	us-gaap	Redeemable Noncontrolling Interest Equity Fair Value RedeemableNoncontrollingInterestEquityFairValue	81598000	usd
	ahr	Noncontrolling Interest Reclassification From Equity NoncontrollingInterestReclassificationFromEquity	-21000	usd
	ahr	Noncontrolling Interest Reclassification From Equity NoncontrollingInterestReclassificationFromEquity	-62000	usd
	ahr	Noncontrolling Interest Reclassification To Equity NoncontrollingInterestReclassificationToEquity	15303000	usd
	ahr	Noncontrolling Interest Reclassification To Equity NoncontrollingInterestReclassificationToEquity	0	usd
	ahr	Redeemable Noncontrolling Interest Distributions RedeemableNoncontrollingInterestDistributions	3000	usd
	ahr	Redeemable Noncontrolling Interest Distributions RedeemableNoncontrollingInterestDistributions	1083000	usd
	ahr	Repurchase Of Redeemable Noncontrolling Interest RepurchaseOfRedeemableNoncontrollingInterest	10771000	usd
	ahr	Repurchase Of Redeemable Noncontrolling Interest RepurchaseOfRedeemableNoncontrollingInterest	15954000	usd
	us-gaap	Minority Interest Change In Redemption Value MinorityInterestChangeInRedemptionValue	-7539000	usd
	us-gaap	Minority Interest Change In Redemption Value MinorityInterestChangeInRedemptionValue	-4098000	usd
	us-gaap	Net Income Loss Attributable To Redeemable Noncontrolling Interest NetIncomeLossAttributableToRedeemableNoncontrollingInterest	-28000	usd
	us-gaap	Net Income Loss Attributable To Redeemable Noncontrolling Interest NetIncomeLossAttributableToRedeemableNoncontrollingInterest	-564000	usd
CY2024Q3	us-gaap	Redeemable Noncontrolling Interest Equity Fair Value RedeemableNoncontrollingInterestEquityFairValue	220000	usd
CY2023Q3	us-gaap	Redeemable Noncontrolling Interest Equity Fair Value RedeemableNoncontrollingInterestEquityFairValue	59961000	usd
CY2023Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	200000000	shares
CY2024Q3	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	200000000	shares
CY2023Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2024Q3	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2024Q3	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2023Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2023Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2024Q3	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2024Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	1000000000	shares
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	1000000000	shares
CY2024Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2024Q1	us-gaap	Sale Of Stock Consideration Received On Transaction SaleOfStockConsiderationReceivedOnTransaction	724625000	usd
CY2024Q1	ahr	Early Payoff Of Mortgage Payable EarlyPayoffOfMortgagePayable	176145000	usd
CY2024Q1	us-gaap	Repayments Of Lines Of Credit RepaymentsOfLinesOfCredit	545010000	usd
CY2024Q3	ahr	Common Stock Conversion Ratio CommonStockConversionRatio	1
CY2024Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2024Q3	us-gaap	Sale Of Stock Consideration Received On Transaction SaleOfStockConsiderationReceivedOnTransaction	451207000	usd
	ahr	Stock Acquired Average Cost Per Share StockAcquiredAverageCostPerShare	37.16
CY2024Q3	ahr	Limited Liability Company Llc Or Limited Partnership Lp Managing Member Or General Partner Ownership Interest With Redemption Features Outstanding LimitedLiabilityCompanyLLCOrLimitedPartnershipLPManagingMemberOrGeneralPartnerOwnershipInterestWithRedemptionFeaturesOutstanding	0.010
CY2023Q4	ahr	Limited Liability Company Llc Or Limited Partnership Lp Managing Member Or General Partner Ownership Interest With Redemption Features Outstanding LimitedLiabilityCompanyLLCOrLimitedPartnershipLPManagingMemberOrGeneralPartnerOwnershipInterestWithRedemptionFeaturesOutstanding	0.010
CY2024Q3	us-gaap	Stock Issued During Period Shares Conversion Of Units StockIssuedDuringPeriodSharesConversionOfUnits	1216571	shares
CY2024Q3	ahr	Common Stock Conversion Ratio CommonStockConversionRatio	1
CY2024Q3	us-gaap	Held To Maturity Securities HeldToMaturitySecurities	90144000	usd
CY2024Q3	us-gaap	Held To Maturity Securities Fair Value HeldToMaturitySecuritiesFairValue	93246000	usd
CY2023Q4	us-gaap	Held To Maturity Securities HeldToMaturitySecurities	86935000	usd
CY2023Q4	us-gaap	Held To Maturity Securities Fair Value HeldToMaturitySecuritiesFairValue	93304000	usd
CY2024Q3	us-gaap	Secured Debt SecuredDebt	1282853000	usd
CY2024Q3	us-gaap	Loans Payable Fair Value Disclosure LoansPayableFairValueDisclosure	1166413000	usd
CY2023Q4	us-gaap	Secured Debt SecuredDebt	1302396000	usd
CY2023Q4	us-gaap	Loans Payable Fair Value Disclosure LoansPayableFairValueDisclosure	1185260000	usd
CY2024Q3	ahr	Linesofcreditandtermloannet Linesofcreditandtermloannet	591490000	usd
CY2024Q3	us-gaap	Line Of Credit Facility Fair Value Of Amount Outstanding LineOfCreditFacilityFairValueOfAmountOutstanding	596903000	usd
CY2023Q4	ahr	Linesofcreditandtermloannet Linesofcreditandtermloannet	1220137000	usd
CY2023Q4	us-gaap	Line Of Credit Facility Fair Value Of Amount Outstanding LineOfCreditFacilityFairValueOfAmountOutstanding	1225890000	usd
CY2024Q3	ahr	Operating Lease Revenue OperatingLeaseRevenue	45168000	usd
CY2023Q3	ahr	Operating Lease Revenue OperatingLeaseRevenue	45582000	usd
CY2024Q3	us-gaap	Operating Lease Variable Lease Income OperatingLeaseVariableLeaseIncome	8975000	usd
CY2023Q3	us-gaap	Operating Lease Variable Lease Income OperatingLeaseVariableLeaseIncome	9800000	usd
	ahr	Operating Lease Revenue OperatingLeaseRevenue	136382000	usd
	ahr	Operating Lease Revenue OperatingLeaseRevenue	137101000	usd
	us-gaap	Operating Lease Variable Lease Income OperatingLeaseVariableLeaseIncome	27776000	usd
	us-gaap	Operating Lease Variable Lease Income OperatingLeaseVariableLeaseIncome	29551000	usd
CY2024Q3	us-gaap	Lessor Operating Lease Payments To Be Received Remainder Of Fiscal Year LessorOperatingLeasePaymentsToBeReceivedRemainderOfFiscalYear	34932000	usd
CY2024Q3	us-gaap	Lessor Operating Lease Payments To Be Received Next Twelve Months LessorOperatingLeasePaymentsToBeReceivedNextTwelveMonths	134056000	usd
CY2024Q3	us-gaap	Lessor Operating Lease Payments To Be Received Two Years LessorOperatingLeasePaymentsToBeReceivedTwoYears	125609000	usd
CY2024Q3	us-gaap	Lessor Operating Lease Payments To Be Received Three Years LessorOperatingLeasePaymentsToBeReceivedThreeYears	119660000	usd
CY2024Q3	us-gaap	Lessor Operating Lease Payments To Be Received Four Years LessorOperatingLeasePaymentsToBeReceivedFourYears	107856000	usd
CY2024Q3	ahr	Lessor Operating Lease Payment To Be Received After Year Four LessorOperatingLeasePaymentToBeReceivedAfterYearFour	508821000	usd
CY2024Q3	us-gaap	Lessor Operating Lease Payments To Be Received LessorOperatingLeasePaymentsToBeReceived	1030934000	usd
CY2024Q3	us-gaap	Operating Lease Cost OperatingLeaseCost	9060000	usd
CY2023Q3	us-gaap	Operating Lease Cost OperatingLeaseCost	11049000	usd
CY2024Q3	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	556000	usd
CY2023Q3	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	334000	usd
CY2024Q3	us-gaap	Finance Lease Interest Expense FinanceLeaseInterestExpense	156000	usd
CY2023Q3	us-gaap	Finance Lease Interest Expense FinanceLeaseInterestExpense	82000	usd
CY2024Q3	us-gaap	Sublease Income SubleaseIncome	144000	usd
CY2023Q3	us-gaap	Sublease Income SubleaseIncome	97000	usd
CY2024Q3	us-gaap	Lease Cost LeaseCost	9628000	usd
CY2023Q3	us-gaap	Lease Cost LeaseCost	11368000	usd
	us-gaap	Operating Lease Cost OperatingLeaseCost	29212000	usd
	us-gaap	Operating Lease Cost OperatingLeaseCost	34445000	usd
	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	1672000	usd
	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	934000	usd
	us-gaap	Finance Lease Interest Expense FinanceLeaseInterestExpense	464000	usd
	us-gaap	Finance Lease Interest Expense FinanceLeaseInterestExpense	239000	usd
	us-gaap	Sublease Income SubleaseIncome	436000	usd
	us-gaap	Sublease Income SubleaseIncome	425000	usd
	us-gaap	Lease Cost LeaseCost	30912000	usd
	us-gaap	Lease Cost LeaseCost	35193000	usd
CY2024Q3	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P12Y1M6D
CY2023Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P12Y2M12D
CY2024Q3	us-gaap	Finance Lease Weighted Average Remaining Lease Term1 FinanceLeaseWeightedAverageRemainingLeaseTerm1	P1Y2M12D
CY2023Q4	us-gaap	Finance Lease Weighted Average Remaining Lease Term1 FinanceLeaseWeightedAverageRemainingLeaseTerm1	P1Y6M
CY2024Q3	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.0585
CY2023Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.0576
CY2024Q3	us-gaap	Finance Lease Weighted Average Discount Rate Percent FinanceLeaseWeightedAverageDiscountRatePercent	0.0822
CY2023Q4	us-gaap	Finance Lease Weighted Average Discount Rate Percent FinanceLeaseWeightedAverageDiscountRatePercent	0.0778
	us-gaap	Finance Lease Interest Payment On Liability FinanceLeaseInterestPaymentOnLiability	467000	usd
	us-gaap	Finance Lease Interest Payment On Liability FinanceLeaseInterestPaymentOnLiability	239000	usd
	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	63000	usd
	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	50000	usd
	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	4322000	usd
	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	6153000	usd
CY2024Q3	us-gaap	Lessee Operating Lease Liability Payments Remainder Of Fiscal Year LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear	8055000	usd
CY2024Q3	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	31314000	usd
CY2024Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	31000000	usd
CY2024Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	31972000	usd
CY2024Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	31923000	usd
CY2024Q3	ahr	Lessee Operating Lease Liability To Be Paid After Year Four LesseeOperatingLeaseLiabilityToBePaidAfterYearFour	136396000	usd
CY2024Q3	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	270660000	usd
CY2024Q3	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	96447000	usd
CY2024Q3	us-gaap	Operating Lease Liability OperatingLeaseLiability	174213000	usd
CY2024Q3	us-gaap	Finance Lease Liability Payments Remainder Of Fiscal Year FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear	8000	usd
CY2024Q3	us-gaap	Finance Lease Liability Payments Due Next Twelve Months FinanceLeaseLiabilityPaymentsDueNextTwelveMonths	31000	usd
CY2024Q3	us-gaap	Finance Lease Liability Payments Due Year Two FinanceLeaseLiabilityPaymentsDueYearTwo	0	usd
CY2024Q3	us-gaap	Finance Lease Liability Payments Due Year Three FinanceLeaseLiabilityPaymentsDueYearThree	0	usd
CY2024Q3	us-gaap	Finance Lease Liability Payments Due Year Four FinanceLeaseLiabilityPaymentsDueYearFour	0	usd
CY2024Q3	ahr	Finance Lease Liability To Be Paid After Year Four FinanceLeaseLiabilityToBePaidAfterYearFour	0	usd
CY2024Q3	us-gaap	Finance Lease Liability Payments Due FinanceLeaseLiabilityPaymentsDue	39000	usd
CY2024Q3	us-gaap	Finance Lease Liability Undiscounted Excess Amount FinanceLeaseLiabilityUndiscountedExcessAmount	2000	usd
CY2024Q3	us-gaap	Finance Lease Liability FinanceLeaseLiability	37000	usd
	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	4	segment
CY2023Q3	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	6	segment
	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	4	segment
CY2024Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	476834000	usd
CY2024Q3	us-gaap	Operating Lease Lease Income OperatingLeaseLeaseIncome	46980000	usd
CY2024Q3	ahr	Revenuesand Government Grant Income From Cares Act RevenuesandGovernmentGrantIncomeFromCARESAct	523814000	usd
CY2024Q3	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	417128000	usd
CY2024Q3	us-gaap	Operating Lease Expense OperatingLeaseExpense	13150000	usd
CY2024Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	93536000	usd
CY2024Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	11921000	usd
CY2024Q3	us-gaap	Business Combination Acquisition Related Costs BusinessCombinationAcquisitionRelatedCosts	3537000	usd
CY2024Q3	us-gaap	Depreciation And Amortization DepreciationAndAmortization	44246000	usd
CY2024Q3	us-gaap	Interest Expense InterestExpense	30395000	usd
CY2024Q3	us-gaap	Gain Loss On Interest Rate Derivative Instruments Not Designated As Hedging Instruments GainLossOnInterestRateDerivativeInstrumentsNotDesignatedAsHedgingInstruments	-8967000	usd
CY2024Q3	us-gaap	Gains Losses On Sales Of Investment Real Estate GainsLossesOnSalesOfInvestmentRealEstate	-4000	usd
CY2024Q3	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-2123000	usd
CY2024Q3	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	2689000	usd
CY2024Q3	us-gaap	Interest And Other Income InterestAndOtherIncome	2138000	usd
CY2024Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-36662000	usd
CY2024Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-2830000	usd
CY2024Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	263000	usd
CY2024Q3	us-gaap	Profit Loss ProfitLoss	-3093000	usd
CY2023Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	416206000	usd
CY2023Q3	us-gaap	Operating Lease Lease Income OperatingLeaseLeaseIncome	46970000	usd
CY2023Q3	ahr	Government Grant Income From Cares Act GovernmentGrantIncomeFromCARESAct	1064000	usd
CY2023Q3	ahr	Revenuesand Government Grant Income From Cares Act RevenuesandGovernmentGrantIncomeFromCARESAct	464240000	usd
CY2023Q3	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	374603000	usd
CY2023Q3	us-gaap	Operating Lease Expense OperatingLeaseExpense	14574000	usd
CY2023Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	75063000	usd
CY2023Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	11342000	usd
CY2023Q3	us-gaap	Business Combination Acquisition Related Costs BusinessCombinationAcquisitionRelatedCosts	1024000	usd
CY2023Q3	us-gaap	Depreciation And Amortization DepreciationAndAmortization	49273000	usd
CY2023Q3	us-gaap	Interest Expense InterestExpense	42005000	usd
CY2023Q3	us-gaap	Gain Loss On Interest Rate Derivative Instruments Not Designated As Hedging Instruments GainLossOnInterestRateDerivativeInstrumentsNotDesignatedAsHedgingInstruments	3402000	usd
CY2023Q3	us-gaap	Gains Losses On Sales Of Investment Real Estate GainsLossesOnSalesOfInvestmentRealEstate	31981000	usd
CY2023Q3	us-gaap	Impairment Of Real Estate ImpairmentOfRealEstate	12510000	usd
CY2023Q3	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-505000	usd
CY2023Q3	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-1704000	usd
CY2023Q3	us-gaap	Interest And Other Income InterestAndOtherIncome	1755000	usd
CY2023Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-19586000	usd
CY2023Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-6162000	usd
CY2023Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	284000	usd
CY2023Q3	us-gaap	Profit Loss ProfitLoss	-6446000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	1386965000	usd
	us-gaap	Operating Lease Lease Income OperatingLeaseLeaseIncome	140963000	usd
	ahr	Revenuesand Government Grant Income From Cares Act RevenuesandGovernmentGrantIncomeFromCARESAct	1527928000	usd
	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	1223321000	usd
	us-gaap	Operating Lease Expense OperatingLeaseExpense	40200000	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	264407000	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	35495000	usd
	us-gaap	Business Combination Acquisition Related Costs BusinessCombinationAcquisitionRelatedCosts	6334000	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	132277000	usd
	us-gaap	Interest Expense InterestExpense	97429000	usd
	us-gaap	Gain Loss On Interest Rate Derivative Instruments Not Designated As Hedging Instruments GainLossOnInterestRateDerivativeInstrumentsNotDesignatedAsHedgingInstruments	-2162000	usd
	us-gaap	Gains Losses On Sales Of Investment Real Estate GainsLossesOnSalesOfInvestmentRealEstate	2257000	usd
	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-4363000	usd
	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	2345000	usd
	us-gaap	Interest And Other Income InterestAndOtherIncome	7107000	usd
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-92245000	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-1944000	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	1227000	usd
	us-gaap	Profit Loss ProfitLoss	-3171000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	1235458000	usd
	us-gaap	Operating Lease Lease Income OperatingLeaseLeaseIncome	141134000	usd
	ahr	Government Grant Income From Cares Act GovernmentGrantIncomeFromCARESAct	7445000	usd
	ahr	Revenuesand Government Grant Income From Cares Act RevenuesandGovernmentGrantIncomeFromCARESAct	1384037000	usd
	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	1117298000	usd
	us-gaap	Operating Lease Expense OperatingLeaseExpense	44422000	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	222317000	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	36169000	usd
	us-gaap	Business Combination Acquisition Related Costs BusinessCombinationAcquisitionRelatedCosts	2244000	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	138644000	usd
	us-gaap	Interest Expense InterestExpense	122006000	usd
	us-gaap	Gain Loss On Interest Rate Derivative Instruments Not Designated As Hedging Instruments GainLossOnInterestRateDerivativeInstrumentsNotDesignatedAsHedgingInstruments	8200000	usd
	us-gaap	Gains Losses On Sales Of Investment Real Estate GainsLossesOnSalesOfInvestmentRealEstate	29777000	usd
	us-gaap	Impairment Of Real Estate ImpairmentOfRealEstate	12510000	usd
	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-924000	usd
	us-gaap	Business Combination Step Acquisition Equity Interest In Acquiree Remeasurement Gain BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain	726000	usd
	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	372000	usd
	us-gaap	Interest And Other Income InterestAndOtherIncome	5952000	usd
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-90413000	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-45153000	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	775000	usd
	us-gaap	Profit Loss ProfitLoss	-45928000	usd
CY2024Q3	us-gaap	Assets Assets	4677012000	usd
CY2023Q4	us-gaap	Assets Assets	4577933000	usd
CY2024Q3	ahr	Revenuesand Government Grant Income From Cares Act RevenuesandGovernmentGrantIncomeFromCARESAct	523814000	usd
CY2023Q3	ahr	Revenuesand Government Grant Income From Cares Act RevenuesandGovernmentGrantIncomeFromCARESAct	464240000	usd
	ahr	Revenuesand Government Grant Income From Cares Act RevenuesandGovernmentGrantIncomeFromCARESAct	1527928000	usd
	ahr	Revenuesand Government Grant Income From Cares Act RevenuesandGovernmentGrantIncomeFromCARESAct	1384037000	usd
CY2024Q3	us-gaap	Real Estate Investment Property Net RealEstateInvestmentPropertyNet	3535943000	usd
CY2023Q4	us-gaap	Real Estate Investment Property Net RealEstateInvestmentPropertyNet	3425438000	usd
CY2024Q3	ahr	Concentration Risk Number Of States That Generated At Least Ten Percent Of Annualized Base Rent ConcentrationRiskNumberOfStatesThatGeneratedAtLeastTenPercentOfAnnualizedBaseRent	3	state
CY2024Q3	ahr	Minimum Percent Share Of Each State Annualized Base Rent That Company Owned MinimumPercentShareOfEachStateAnnualizedBaseRentThatCompanyOwned	0.100
CY2024Q3	ahr	Number Of Tenants With More Than Ten Percent Of Annual Base Rent NumberOfTenantsWithMoreThanTenPercentOfAnnualBaseRent	0	tenant
CY2024Q3	ahr	Minimum Percent Share Of Annualized Base Rent Accounted By Tenants MinimumPercentShareOfAnnualizedBaseRentAccountedByTenants	0.100
CY2024Q3	ecd	Non Rule10b51 Arr Adopted Flag NonRule10b51ArrAdoptedFlag	false
CY2024Q3	ecd	Rule10b51 Arr Adopted Flag Rule10b51ArrAdoptedFlag	false
CY2024Q3	ecd	Rule10b51 Arr Trmntd Flag Rule10b51ArrTrmntdFlag	false
CY2024Q3	ecd	Non Rule10b51 Arr Trmntd Flag NonRule10b51ArrTrmntdFlag	false

Files In Submission

Name	View Source	Status
0001632970-24-000121-index-headers.html	Edgar Link	pending
0001632970-24-000121-index.html	Edgar Link	pending
0001632970-24-000121.txt	Edgar Link	pending
0001632970-24-000121-xbrl.zip	Edgar Link	pending
ahr-20240930.htm	Edgar Link	pending
ahr-20240930.xsd	Edgar Link	pending
ex101-2024xq310xqahr.htm	Edgar Link	pending
ex311-2024xq310xqahr.htm	Edgar Link	pending
ex312-2024xq310xqahr.htm	Edgar Link	pending
ex321-2024xq310xqahr.htm	Edgar Link	pending
ex322-2024xq310xqahr.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
ahr-20240930_pre.xml	Edgar Link	unprocessable
ahr-20240930_htm.xml	Edgar Link	completed
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R78.htm	Edgar Link	pending
R79.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R80.htm	Edgar Link	pending
R81.htm	Edgar Link	pending
R82.htm	Edgar Link	pending
R83.htm	Edgar Link	pending
R84.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
ahr-20240930_cal.xml	Edgar Link	unprocessable
ahr-20240930_def.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
ahr-20240930_lab.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$AHR
American Healthcare REIT, Inc. Stock $ahr

2024 Q4 Form 10-Q Financial Statement

#000163297024000121 Filed on November 13, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$AHR American Healthcare REIT, Inc. Stock $ahr

2024 Q4 Form 10-Q Financial Statement

#000163297024000121 Filed on November 13, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$AHR
American Healthcare REIT, Inc. Stock $ahr